(Q38988645)

English

Brief Report: Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Brief Report: Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Séverine Loisel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Joëlle Dulong

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Cédric Ménard

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Marie-Laure Renoud

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Nadine Meziere

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Bezier Isabelle

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Maëlle Latour

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Nadège Bescher

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Nicolas Bertheuil

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Luc Sensebé

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Karin Tarte

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1431-1436

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Clinical Trials With Mesenchymal Stem Cells: An Update.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Good manufacturing practices production of mesenchymal stem/stromal cells.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Comparison of biological properties of umbilical cord-derived mesenchymal stem cells from early and late passages: immunomodulatory ability is enhanced in aged cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Mesenchymal stromal cell 'licensing': a multistep process

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Matrix metalloproteinase-7 and the 20S proteasome contribute to cellular senescence

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2580

21 January 2018

Identifiers

10.1002/STEM.2580

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28142215%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38988645&oldid=1744388242"